Cangzhou Nanobody Technology Innovation Center, Cangzhou Medical College, Cangzhou, 061001, China.
Cangzhou Nanobody Technology Innovation Center, Cangzhou Medical College, Cangzhou, 061001, China.
Protein Expr Purif. 2021 Aug;184:105808. doi: 10.1016/j.pep.2020.105808. Epub 2020 Dec 11.
The gene encoding the phage major capsid protein 10A was cloned into the prokaryotic expression vector pET24a, and a 6XHis-tag was fused to the 3'-end of the 10A gene to verify complete expression. The recombinant plasmid was transformed into Escherichia coli (E. coli) BL21 (DE3) cells, and 10A expression was induced by IPTG. SDS-PAGE and Western blot were used to confirm the target protein expression. The T7Select10-3b vector was added to the cultured bacteria expressing 10A at a multiplicity of infection (MOI) ranging from 0.01 to 0.1, and complete lysis of the bacteria was monitored by absorbance changes in the medium. The recombinant phage (reP) was harvested by PEG/NaCl sedimentation and resuspended in PBS. ELISA was performed to verify the presence of the 6XHis-tag on the surface of reP. The 10A-fusion expression vectors (pET10A-flag, pET10A-egfp, and pET10A-pct) were constructed, and fusion proteins were expressed and detected by the same method. The corresponding rePs (reP-Flag, reP-EGFP, and reP-PCT) were prepared by T7Select10-3b infection. After the expression of the peptides/proteins on the reP surfaces was confirmed, reP-Flag and reP-PCT were used to immunize mice to prepare anti-Flag and anti-PCT antibodies. The results showed that rePs prepared using the 10A-fusion vector and T7Select10-3b can be used as antigens to immunize mice and prepare antibodies. This method may be able to meet the rapid antigen preparation requirements for antibody production. Notably, the recombinant phage (reP) described in this study was obtained by the sedimentation method from T7Select10-3b-infected E. coli BL21 (DE3) cells carrying the major capsid protein 10A expression vector or 10A-fusion protein vector.
噬菌体主要衣壳蛋白 10A 的基因被克隆到原核表达载体 pET24a 中,并在 10A 基因的 3'端融合了 6XHis 标签,以验证其完全表达。将重组质粒转化到大肠杆菌(E. coli)BL21(DE3)细胞中,并用 IPTG 诱导 10A 的表达。通过 SDS-PAGE 和 Western blot 验证目的蛋白的表达。将 T7Select10-3b 载体加入到表达 10A 的培养菌中,感染复数(MOI)范围从 0.01 到 0.1,通过培养基吸光度的变化监测细菌的完全裂解。通过 PEG/NaCl 沉淀收获重组噬菌体(reP),并悬浮在 PBS 中。通过 ELISA 验证 reP 表面存在 6XHis 标签。构建了 10A-融合表达载体(pET10A-flag、pET10A-egfp 和 pET10A-pct),并通过相同的方法表达和检测融合蛋白。通过 T7Select10-3b 感染制备相应的 reP(reP-Flag、reP-EGFP 和 reP-PCT)。在确认 reP 表面的肽/蛋白表达后,用 reP-Flag 和 reP-PCT 免疫小鼠制备抗 Flag 和抗 PCT 抗体。结果表明,使用 10A-融合载体和 T7Select10-3b 制备的 reP 可以作为抗原免疫小鼠并制备抗体。该方法可能能够满足抗体生产中快速抗原制备的要求。值得注意的是,本研究中描述的重组噬菌体(reP)是通过沉淀法从携带主要衣壳蛋白 10A 表达载体或 10A-融合蛋白载体的 T7Select10-3b 感染的大肠杆菌 BL21(DE3)细胞中获得的。